As expected, GB2, GB3, and GB4 core regions showed a more drug-resistant behavior compared to peripheral tumor portions (28) in particular, GB2c was assessed as MR and GB2p as HR, while GB3c/4c were NR and GB3p/4p were LR. This evidence concerns the gene GABBR2 and neoplasm.